FI920268A0 - Tricykliskt pyridonderivat. - Google Patents

Tricykliskt pyridonderivat.

Info

Publication number
FI920268A0
FI920268A0 FI920268A FI920268A FI920268A0 FI 920268 A0 FI920268 A0 FI 920268A0 FI 920268 A FI920268 A FI 920268A FI 920268 A FI920268 A FI 920268A FI 920268 A0 FI920268 A0 FI 920268A0
Authority
FI
Finland
Prior art keywords
tricycliskt
pyridonderivat
compound
formula
sleep
Prior art date
Application number
FI920268A
Other languages
English (en)
Other versions
FI920268A (fi
Inventor
Richard Raimund Scherschlicht
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI920268A0 publication Critical patent/FI920268A0/fi
Publication of FI920268A publication Critical patent/FI920268A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Electric Propulsion And Braking For Vehicles (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI920268A 1991-01-25 1992-01-22 Tricykliskt pyridonderivat. FI920268A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH22891 1991-01-25

Publications (2)

Publication Number Publication Date
FI920268A0 true FI920268A0 (fi) 1992-01-22
FI920268A FI920268A (fi) 1992-07-26

Family

ID=4182207

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920268A FI920268A (fi) 1991-01-25 1992-01-22 Tricykliskt pyridonderivat.

Country Status (30)

Country Link
US (2) US5281711A (fi)
EP (1) EP0496274B1 (fi)
JP (1) JPH0739415B2 (fi)
KR (1) KR920014811A (fi)
AT (1) ATE140002T1 (fi)
AU (1) AU649302B2 (fi)
BG (1) BG61057B2 (fi)
BR (1) BR9200217A (fi)
CA (1) CA2058640A1 (fi)
CZ (1) CZ280258B6 (fi)
DE (1) DE59206676D1 (fi)
DK (1) DK0496274T3 (fi)
ES (1) ES2089252T3 (fi)
FI (1) FI920268A (fi)
GR (1) GR3021126T3 (fi)
HU (2) HU207072B (fi)
IE (1) IE920225A1 (fi)
IL (1) IL100702A (fi)
IS (1) IS3804A (fi)
LT (1) LT3473B (fi)
LV (1) LV10275B (fi)
MX (1) MX9200242A (fi)
MY (1) MY108199A (fi)
NO (1) NO920338L (fi)
NZ (1) NZ241341A (fi)
RU (1) RU2073678C1 (fi)
SI (1) SI9210067A (fi)
UY (1) UY23362A1 (fi)
YU (1) YU48221B (fi)
ZA (1) ZA92361B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법
US7277767B2 (en) 1999-12-10 2007-10-02 Srs Labs, Inc. System and method for enhanced streaming audio
US8445700B2 (en) 2008-11-24 2013-05-21 Council Of Scientific & Industrial Research Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines
US9258664B2 (en) 2013-05-23 2016-02-09 Comhear, Inc. Headphone audio enhancement system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191427B (en) * 1984-07-16 1987-02-27 Budapesti Mueszaki Egyetem,Hu Piezooptical effect reduced electrooptical light modulator
ZW17385A1 (en) * 1984-11-06 1986-02-19 Hoffmann La Roche Tricyclic pyridine derivatives
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
DK0496274T3 (da) 1996-09-23
KR920014811A (ko) 1992-08-25
JPH0739415B2 (ja) 1995-05-01
HUT60266A (en) 1992-08-28
EP0496274A1 (de) 1992-07-29
ES2089252T3 (es) 1996-10-01
HU9200128D0 (en) 1992-04-28
CZ280258B6 (cs) 1995-12-13
NO920338D0 (no) 1992-01-24
HU211259A9 (en) 1995-11-28
YU6792A (sh) 1994-11-15
LV10275A (lv) 1994-10-20
SI9210067A (en) 1995-02-28
BG61057B2 (bg) 1996-09-30
IS3804A (is) 1992-07-26
BR9200217A (pt) 1992-10-06
JPH04312585A (ja) 1992-11-04
IE920225A1 (en) 1992-07-29
IL100702A (en) 1995-08-31
HU207072B (en) 1993-03-01
YU48221B (sh) 1997-08-22
ZA92361B (en) 1992-09-30
LT3473B (en) 1995-10-25
NZ241341A (en) 1993-12-23
LTIP801A (en) 1995-02-27
EP0496274B1 (de) 1996-07-03
MY108199A (en) 1996-08-30
ATE140002T1 (de) 1996-07-15
RU2073678C1 (ru) 1997-02-20
LV10275B (en) 1995-02-20
MX9200242A (es) 1992-07-01
AU1034092A (en) 1992-07-30
CS18292A3 (en) 1992-08-12
CA2058640A1 (en) 1992-07-26
IL100702A0 (en) 1992-09-06
NO920338L (no) 1992-07-27
US5326769A (en) 1994-07-05
UY23362A1 (es) 1992-07-21
GR3021126T3 (en) 1996-12-31
DE59206676D1 (de) 1996-08-08
AU649302B2 (en) 1994-05-19
FI920268A (fi) 1992-07-26
US5281711A (en) 1994-01-25

Similar Documents

Publication Publication Date Title
FI934223A0 (fi) Heterocykliscykliska aminderivat
BG102600A (en) Carbamoyloxy derivatives of mutilin and their use as bactericides
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
NO975747D0 (no) Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler
MY116124A (en) Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
ID22042A (id) Benzonaftiridin sebagai pengobatan cabang tenggorokan
AU5648496A (en) Pyrazolo-(1,5a)pyrimidines, their preparation and their use
FI920268A (fi) Tricykliskt pyridonderivat.
ATE39694T1 (de) (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung.
PT775143E (pt) Novos derivados de 3h-2,3-benzodiazepina 3-substituidos sua preparacao e utilizacao
DE69526519D1 (de) Silylierungsprocess
ES2054050T3 (es) (+) 1-((3,4,5-trimetoxi)benciloximetil)-1-fenil-n,n-dimetil-n-propilamina, su procedimiento de preparacion y su aplicacion en terapeutica.
ATE207480T1 (de) Substituierte aminoalkylaminopyridine
ATE134135T1 (de) Ein imidazobenzodiazepin zur behandlung von schlafstörungen
DE3874361D1 (de) Als analgetika verwendbare 1-((4-morpholinyl)alkyl)-1h-indole und deren herstellung.
AU8377691A (en) Use of N-(1-hexahydroazepinylalkyl)acetamides for the treatment of cholinergic transmission disorders
MX9803271A (es) Uso de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,6-tetrahid ropiridina para la preparacion de farmacos para el tratamiento de esclerosis lateral aminotrofica.

Legal Events

Date Code Title Description
FD Application lapsed